Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
A common research protocol: BPC-157: 250500 mcg daily (subcutaneous near injury) TB-500: 2.5 mg twice weekly (subcutaneous) Duration: 48 weeks The Bottom Line Neither peptide is universally "better" they excel in different contexts and work through different mechanisms
BPC-157 also interacts with the nitric-oxide system (eNOS/NO), which may underlie its vasodilatory and perfusion benefits during healing
This is done under a doctors care
Depending on the degree of the deficiency, your doctor may recommend that you receive subsequent injections over a few weeks or ongoing, routine appointments
The knowledge of the literature and the awareness of the shortcomings of the current knowledge base allows having knowledgeable conversations on the role of this peptide in the rest of the scientific world
